This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. (doing business as Charles River) for the manufacture and safety testing of experimental virus vaccines. The contract has a ceiling value of $180,478.80 and is a firm fixed-price delivery order with a final completion date of July 31, 2020. The contract was not set aside for any specific business type. Through this award, Charles River,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River), a global contract research organization. The $6,732 delivery order contract is for a period of performance ending on November 30, 2011, and covers a Statement of Work (SOW) related to NIAID-15-101211. The contract is not set aside for any specific business type. Charles River has...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a firm fixed-price delivery order contract to Charles River Laboratories, Inc. (Charles River) to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $180,360.00 and runs through June 20, 2017. This award was not set aside for any socioeconomic program. As a leading provider of research-related products and...
This federal contract award is for the manufacture and safety testing of experimental virus vaccines. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor Charles River Laboratories, Inc. The contract has a ceiling value of $11,111.40 and was awarded on September 20, 2013 with a completion date of September 22, 2014. The contract did not utilize a set-aside. Charles River...
This federal contract award, valued at $164,622.60, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract is a delivery order with a firm fixed price. Charles River Laboratories is a global contract research organization that provides a wide range of research-related products and services to government agencies, including laboratory animals, diagnostic...
This is a $178,761.60 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has no set-aside designation. Charles River is a global contract research organization that provides specialized research products and services to government agencies, including laboratory animals, diagnostic testing, virus...
This is a federal contract award to Charles River Laboratories, Inc. (doing business as Charles River), a global contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for the provision of clinical trial materials for virus vaccines, with a ceiling value of $296,136.10 and a performance period through September 30, 2025. The contract is a delivery order and is priced on a firm...
This is a firm-fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River) to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $178,790.70 and a completion date of January 11, 2016. This order was placed under an existing indefinite delivery contract with Charles River, likely to support NIAID's ongoing...
This is a federal contract award to Charles River Laboratories, Inc. (Charles River) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $187,327.80 firm fixed-price contract is for the manufacture and safety testing of experimental virus vaccines. The contract does not have a set-aside designation. Charles River is a leading provider of research products and services to government agencies, including laboratory...
This is a federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. for the provision of clinical trial materials for virus vaccines. The contract has a ceiling value of $374,769.10 and a period of performance ending on September 30, 2025. It is a firm fixed-price contract with no set-aside designation. Charles River Laboratories is a global contract...